|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
Wnt |
|
�ź�ת�� |
|
Ƥ������ |
| ��������������� | |
|
��ӻ� |
|
���Ŀ� |
| PubMed | |
|
Article by |
|
Article by |
Wnt�ź�ת��ͨ·������Ƥ�������е�����
��ӻ�, ���Ŀ�
���ľ�ҽ��ѧ����ҽԺȫ��Ƥ���Բ����� ���� 710032
Wnt�ź�ת��ͨ·����̥��������������������ء�Ŀǰ��ΪWntͨ·�������Ҫ����:ϸ��������Wnt����Ĥ����������ס�ɢ�ҵ��ס��᳦������Ϣ�ⲡ��������-��������Tϸ������/�ܰ�����ǿ���ӵ�һϵ�е��ס�ϸ��������Wnt������ź��������Ϻ�,ͨ�����ʵ���һϵ�������,�ܹ�ʹ�����ڦ�-�������ױ����ȶ����ۻ�,���������ת¼����Tϸ������/�ܰ�����ǿ�����������ü���л����ת¼,������Wnt�ź�ͨ·�IJ�ͬ���и��ֵ������ӽ��е��ء�Wnt�ź�ͨ·���쳣����������ijЩ�����ķ�������չ�йء�
[2] Pham K, Milovanovic T, Barr RJ, et al. Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features. Mol Pathol, 2003, 56:280-285.
[3] Weeraratna AT, Jiang Y, Hostetter G,et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell, 2002, 1:279-288.
[4] Demunter A, Libbrecht L, Degreef H,et al. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.Mod Pathol. 2002, 15:454-461.
[5] Maelandsmo GM, Holm R, Nesland JM, et al. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin Cancer Res, 2003, 9:3383-3388.
[6] Rubinfeld B, Robbins P, El-Gamil M,et al. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science, 1997, 275:1790-1792.
[7] Omholt K, Platz A, Ringborg U, et al. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma. Int J Cancer, 2001, 92:839.
[8] Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, et al. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev, 2002, 16:2058-2072.
[9] Murakami T, Toda S, Fujimoto M,et al. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Biochem Biophys Res Commun, 2001, 288:8-15.
[10] Yamazaki F, Aragane Y, Kawada A, et al. Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma. Br J Dermatol, 2001, 145:771-777.
[11] Lo Muzio L, Pannone G, Staibano S, et al. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin. Anticancer Res, 2002, 22:565-576.
[12] Boonchai W, Walsh M, Cummings M, et al. Expression of beta-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma. Arch Dermatol, 2000, 136:937-938.
[13] Hassanein AM, Glanz SM. Beta-catenin expression in benign and malignant pilomatrix neoplasms. Br J Dermatol, 2004, 150:511-516.